Ingredient record · Nerve pain medicine
Pregabalin: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
1 entry containing Pregabalin is on India's banned-drugs list, and 0 are banned today. 24 batches of medicines containing Pregabalin failed a government lab test between August 2019 and July 2026, from 21 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
On the banned-drugs list
Pregabalin on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Pregabalin (SR) 75mg + Nortriptyline 10mg + Vitamin D3 2000IU + Mecobalamin 1500mcg TabletFixed-dose combination · vitamins | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 12 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Pregabalin | 7 | 6 | Jul 2026 |
| Pregabalin Methylcobalamin | 6 | 6 | Mar 2026 |
| Pregabalin Nortriptyline | 2 | 2 | May 2026 |
| Pregabalin Nortripyline Methylcobalamin | 1 | 1 | Jul 2026 |
| Pregabalin L Methyl Folate Calcium Pyridoxal Phosphate Alpha Lipoic Acid Methylcobalamin | 1 | 1 | Mar 2026 |
| Pregabaline Nortriptyline | 1 | 1 | Dec 2025 |
| Baptar Nm | 1 | 1 | Oct 2025 |
| Pregabalin Methlcobalamin | 1 | 1 | Oct 2025 |
| Pregabalin Methylcobala Min | 1 | 1 | Feb 2025 |
| Pregabalin Methylcobal Amin | 1 | 1 | Jan 2025 |
| Loose Green Color Purported To Be Contains Tramadol Pregabalin Other | 1 | 0 | Apr 2023 |
| Pgab Mb | 1 | 1 | Aug 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Pregabalin IP 75mg, Nortripyline 10mg and Methylcobalamin IP 1500mcg, | ADT252729AMfg 2025-10 · Exp 2027-09 | Astonea Labs Pvt. LtdHaryana | The content of Methylcobalamin found to be 668.61 mcg per tablet (44.574%) against labelled claim of 1500 mcg per tablet.Labelling | Govt Analyst PunjabState lab | Jul 2026 |
| Pregabalin Capsules IP 300mg | DMC-260508AMfg 2026-05 · Exp 2028-04 | Divine Medicare | The Contents of Pregabali found to be 211.16mg/Capsule against the claim of 300.0mg/Capsule.Other | Govt Analyst PunjabState lab | Jul 2026 |
| Pregabalin capsules IP 300 mg | SC2602602Mfg 2026-02 · Exp 2028-01 | Scout Lifescience Pvt. LtdHaryana | The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution and DescriptionDissolution | CDTL, MumbaiCDSCO lab | May 2026 |
| Pregabalin & Nortriptyline Tablets | ST25417CMfg 2025-11 · Exp 2027-10 | Sahika Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to Manufacturer's Specification with respect to Assay of PregabalinAssay | CDL, KolkataCDSCO lab | May 2026 |
| Pregabalin, L-Methyl folate Calcium, Pyridoxal 5 Phosphate, Alpha lipoic acid & Methylcobalamin Tablets | MT-250016Mfg 2025-01 · Exp 2026-12 | Matins Healthcare Pvt. LtdUttarakhand | Test for DisintegrationDisintegration | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Pregabalin & Methylcobalamin Capsules IP | PGC2508006CMfg 2025-08 · Exp 2027-01 | Asterisk Healthcare | DissolutionDissolution | SDTL, PunjabState lab | Mar 2026 |
| Pregabalin & Methylcobalamin Capsule IP | 25DC015AMfg 2025-08 · Exp 2027-01 | Mas Kashmik Formulation Pvt. Ltd. Pf-13Gujarat | The content of MethylcobalminOther | FDAL, MumbaiState lab | Mar 2026 |
| Pregabalin capsules IP 300mg | LPC25138Mfg 2025-12 · Exp 2027-11 | Levotic Pharma | The contents of Pregabalin found to be 345.40mg per Capsule (115.13%) against labeled claim of 300.0mg per capsule.Labelling | SDTL, PunjabState lab | Feb 2026 |
| Pregabalin & Nortriptyline Tablets | PT-042515Mfg 2025-04 · Exp 2027-03 | Primus PharmaceuticalsHimachal Pradesh | The sample does not conform to the claim with respect to Assay in Nortriptyline.Assay | DTL JaipurState lab | Jan 2026 |
| Pregabaline & Nortriptyline Tablets (DGABA-N Tablets,) | VGT242301BMfg 2024-11 · Exp 2026-10 | Vrindavan GlobalHimachal Pradesh | Misbranded.Misbranded | DCL TelanganaState lab | Dec 2025 |
| Pregabalin & Methlcobalamin Capsules IP (Neujan Capsules) | MMC-1957Mfg 2024-01 · Exp 2025-12 | Mayoford PharmaHimachal Pradesh | Test for Uniformity of WeightUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Baptar NM Tablet (Pregabalin Methylcobalamin & Nortriptyline Tablets) | UGT-25134EMfg 2025-01 · Exp 2026-12 | Ultra Drugs Pvt. LtdHimachal Pradesh | AssayAssay | DTL Baddi H.PState lab | Oct 2025 |
| PREGABALIN AND METHYLCOBALA MIN CAPSULES (Amalin Plus ) | MDP- 774Mfg ? · Exp ? | Medinok Healthcare Pvt. LtdPuducherry | The sample received is labelled as PREGABALIN AND METHYLCOBALAMIN CAPSULES, however PREGABALIN AND METHYLCOBALAMIN CAPSULES is an official IP monograph (2022) hence should be labelled as PREGABALIN AND METHYLCOBALAMIN CAPSULES IP- MisbrandedMisbranded | PuducherryState lab | Feb 2025 |
| Pregabalin (SR) & Methylcobal amin Tablet (Mecoben ? PG) | MP - 240724Mfg 2024-10 · Exp 2026-09 | Medistark Biotech Pvt. Ltd. R.S.No. 68/4 | The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. - MisbrandedMisbranded | State Lab PuducherryState lab | Jan 2025 |
| Pregabalin SR 75 and Methylcobalamin 1500 mcg Tablets | PMC-2311Mfg 2023-09 · Exp 2025-08 | Seeko biotics | Assay of Pregabalin and Methylcobalamin, Dissolution of Pregabalin and DescriptionAssay | CDL KolkataCDSCO lab | Dec 2023 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.